Published in Ophthalmology on December 22, 2009
Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev (2010) 3.24
The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83
Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts. Am J Hum Genet (2012) 1.54
Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica (2012) 1.45
Ocular manifestations of idiopathic aplastic anemia: retrospective study and literature review. Clin Ophthalmol (2014) 0.95
Thrombocytopenia and absent radii (TAR) syndrome associated with bilateral congenital cataract: a case report. J Med Case Rep (2012) 0.90
Vitreous hemorrhage secondary to retinal vasculopathy in a patient with dyskeratosis congenita. Int Ophthalmol (2013) 0.84
Fanconi anemia proteins and their interacting partners: a molecular puzzle. Anemia (2012) 0.82
Adult-onset Diamond-Blackfan anemia with a novel mutation in the exon 5 of RPL11: too late and too rare. Clin Case Rep (2015) 0.81
Dyskeratosis congenita: a report of two cases. Case Rep Dent (2013) 0.79
Dyskeratosis congenita caused by a novel TERT point mutation in siblings with pancytopenia and exudative retinopathy. Pediatr Blood Cancer (2014) 0.78
Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita. Int Ophthalmol (2012) 0.77
Dyskeratosis Congenita Without Oral Involvement: A Rare Hereditary Disease. Oman Med J (2015) 0.75
Bilateral Proliferative Retinopathy Associated With Hoyeraal-Hreidarsson Syndrome, a Severe Form of Dyskeratosis Congenita. Ophthalmic Surg Lasers Imaging Retina (2016) 0.75
Microphthalmos, orbital cyst, and missing thumbs: A rare case report. Oman J Ophthalmol (2016) 0.75
PERIPHERAL RETINOPATHY ASSOCIATED WITH APLASTIC ANEMIA. Retin Cases Brief Rep (2016) 0.75
Frosted Branch Angiitis in Pediatric Dyskeratosis Congenita: A Case Report. Medicine (Baltimore) (2016) 0.75
Ocular involvement in primary immunodeficiency diseases. J Clin Immunol (2013) 0.75
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Prevalence of refractive error in the United States, 1999-2004. Arch Ophthalmol (2008) 3.06
Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis (2001) 2.69
Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program (2007) 2.01
Shwachman-Diamond syndrome: report from an international conference. J Pediatr (2002) 1.99
Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity. Br J Haematol (2004) 1.87
Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature. J Med Genet (1975) 1.77
Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie (2007) 1.72
The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev (2007) 1.56
Diamond-Blackfan anaemia in the U.K.: analysis of 80 cases from a 20-year birth cohort. Br J Haematol (1996) 1.51
Fanconi anemia in black African children. Am J Med Genet (1990) 1.44
Dyskeratosis congenita. J Med Genet (1988) 1.44
Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? J Med Genet (1992) 1.40
Elevated red cell adenosine deaminase activity: a marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases. Br J Haematol (1988) 1.38
Inherited aplastic anaemias/bone marrow failure syndromes. Blood Rev (2007) 1.26
Dyskeratosis congenita: clinical and genetic heterogeneity. Report of a new case and review of the literature. Am J Pediatr Hematol Oncol (1992) 1.21
Bilateral coats retinopathy associated with aplastic anaemia and mild dyskeratotic signs. Am J Med Genet (1994) 1.16
Dyskeratosis congenita: two examples of this multisystem disorder. Pediatrics (1983) 1.15
Normal eye growth in emmetropic schoolchildren. Optom Vis Sci (2004) 1.14
Ocular neovascularization in a patient with Fanconi anemia. Can J Ophthalmol (2006) 1.13
Bone marrow failure syndromes in children. Pediatr Clin North Am (2002) 1.10
The sagittal growth of the eye. 1. Ultrasonic measurement of the depth of the anterior chamber from birth to puberty. Acta Ophthalmol (Copenh) (1971) 1.01
Dyskeratosis congenita. Report of a large kindred. Br J Dermatol (1981) 0.90
Proliferative retinopathy as a complication of dyskeratosis congenita. Retin Cases Brief Rep (2009) 0.87
Bilateral retinal vasculopathy in a patient with dyskeratosis congenita. Arch Ophthalmol (2008) 0.86
Gender variation in ocular biometry and ultrasound biomicroscopy of primary angle closure suspects and normal eyes. J Glaucoma (2007) 0.85
Dyskeratosis congenita (Zinsser-Cole-Engman syndrome). An autopsy case presenting with rectal carcinoma, non-cirrhotic portal hypertension, and Pneumocystis carinii pneumonia. Virchows Arch A Pathol Anat Histopathol (1990) 0.85
Association of the congenital bone marrow failure syndromes with retinopathy, intracerebral calcification and progressive neurological impairment. Eur J Paediatr Neurol (2002) 0.82
Bone marrow failure syndromes. Clin Lab Med (1999) 0.81
Ocular hypertelorism and exotropia as presenting signs in Diamond-Blackfan anemia. Jpn J Ophthalmol (2009) 0.81
The neuroradiological findings in a case of Revesz syndrome. Pediatr Radiol (2007) 0.80
Dyskeratosis congenita with corneal limbal insufficiency. Pediatr Blood Cancer (2009) 0.79
Retinal vasculopathy in Fanconi anemia: a case report. Retina (2005) 0.79
[Zinsser-Engman-Cole syndrome (dyskeratosis congenita) with severe sicca syndrome, panuveitis and corneal perforation--a case report]. Klin Monbl Augenheilkd (2001) 0.79
[Fundus changes in Zinsser-Engman-Cole syndrome (author's transl)]. Klin Monbl Augenheilkd (1975) 0.79
Fanconi anemia and primary cataracts: first case. Ophthalmic Genet (2002) 0.78
Chronic keratoconjunctivitis associated with congenital dyskeratosis and erythrokeratodermia variablis. Two rare genodermatoses. Ophthalmology (1998) 0.78
Infantile glaucoma associated with the Diamond-Blackfan syndrome. J Pediatr Ophthalmol Strabismus (1992) 0.78
An unusual ocular manifestation in Fanconi anemia: congenital glaucoma. Am J Hematol (2005) 0.78
Ocular findings in dyskeratosis congenita. Birth Defects Orig Artic Ser (1982) 0.78
[Eye involvement in dyskeratosis congenita (Zinsser-Cole-Engman syndrome)]. Klin Monbl Augenheilkd (1972) 0.78
Increased crystalline lens thickness and phacomorphic glaucoma in patients with Fanconi anemia. J Cataract Refract Surg (2006) 0.78
Retinal hemorrhages in a patient with dyskeratosis congenita. J AAPOS (2008) 0.77
The association of registered nurse staffing levels and patient outcomes: systematic review and meta-analysis. Med Care (2007) 6.09
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer (2009) 6.00
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol (2008) 4.41
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Cancer in dyskeratosis congenita. Blood (2009) 4.28
Hematotoxicity in workers exposed to low levels of benzene. Science (2004) 4.19
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12
Cancer incidence in persons with Fanconi anemia. Blood (2002) 4.05
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev (2010) 3.24
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol (2010) 3.09
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood (2013) 2.82
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood (2006) 2.82
Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Haematologica (2008) 2.72
Dyskeratosis congenita. Hematol Oncol Clin North Am (2009) 2.45
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst (2006) 2.42
Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev (2010) 2.34
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet (2013) 2.10
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature (2011) 2.03
Fanconi anemia. Semin Hematol (2006) 1.99
Shwachman-Diamond syndrome: report from an international conference. J Pediatr (2002) 1.99
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev (2011) 1.98
Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood (2004) 1.97
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer (2009) 1.91
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica (2011) 1.71
Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood (2012) 1.69
p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch Pathol Lab Med (2002) 1.64
Cancer in Fanconi anemia. Blood (2003) 1.63
Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab (2007) 1.63
Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY) (2010) 1.62
Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol (2004) 1.56
The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev (2007) 1.56
The association of telomere length and genetic variation in telomere biology genes. Hum Mutat (2010) 1.53
Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.48
All in the family: disclosure of "unwanted" information to an adolescent to benefit a relative. Am J Med Genet A (2008) 1.44
Improving quality assessment through multilevel modeling: the case of nursing home compare. Health Serv Res (2007) 1.41
Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer (2010) 1.41
Designing a measure of Complexity Compression in registered nurses. West J Nurs Res (2010) 1.39
Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res (2011) 1.37
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol (2007) 1.37
Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry. Haematologica (2010) 1.36
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control (2009) 1.32
The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. Support Cancer Ther (2006) 1.30
Nurse staffing and quality of patient care. Evid Rep Technol Assess (Full Rep) (2007) 1.30
Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood (2002) 1.27
How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel. Am J Med Genet A (2011) 1.23
A role for heterochromatin protein 1γ at human telomeres. Genes Dev (2011) 1.22
Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22
Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol (2013) 1.20
Future development of nursing home quality indicators. Gerontologist (2005) 1.20
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol (2010) 1.17
Genome-wide association study of relative telomere length. PLoS One (2011) 1.16
Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene. Cancer Res (2005) 1.16
Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita. Int J Hematol (2006) 1.13
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord (2011) 1.12
LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med Genet (2010) 1.11
Individualized risks of first adverse events in patients with Fanconi anemia. Blood (2004) 1.09
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2006) 1.09
Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. Int J Cancer (2013) 1.08
A quality-based payment strategy for nursing home care in Minnesota. Gerontologist (2007) 1.08
Current diagnosis of inherited bone marrow failure syndromes. Pediatr Hematol Oncol (2007) 1.08
Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One (2013) 1.07
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07
Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07
Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control (2011) 1.07
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet (2013) 1.05
Telomere biology in hematopoiesis and stem cell transplantation. Blood Rev (2011) 1.05
Sources of uncertainty and their association with medical decision making: exploring mechanisms in Fanconi anemia. Ann Behav Med (2013) 1.05
The long and short of telomeres and cancer association studies. J Natl Cancer Inst (2013) 1.04
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet (2012) 1.04
Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia. Br J Haematol (2012) 1.01
Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet (2010) 1.01